CTGov Compliance My Organizations

Compliance Rate

Compliance Rate 0%

Compliant submissions 0

Incompliant submissions 0

Total trials 0

My Organizations' Clinical Trials

Showing 500 of 518 entries

View as:

Observational Study of Prosthetic Tissue Aortic and Mitral Heart Valve

Phase: N/A Priority: Normal

NCT ID: NCT00329667 Org: User:

Start: 01/31/03 End: 09/30/08 Due: 09/30/09

TactiCath® Prospective Effectiveness Pilot Study

Phase: N/A Priority: Normal

NCT ID: NCT02131337 Org: User:

Start: 12/31/10 End: 10/31/11 Due: 10/31/12

MitraClip EXPAND G4 Study

Phase: N/A Priority: Normal

NCT ID: NCT04177394 Org: User:

Start: 01/17/20 End: 03/31/28 Due: 03/31/29

To Pace or Not to Pace in Sinus Node Disease

Phase: N/A Priority: Normal

NCT ID: NCT02485093 Org: User:

Start: 06/30/09 End: 10/31/14 Due: 10/31/15

Amulet™ ADVANCE LAA

Phase: N/A Priority: Normal

NCT ID: NCT05997446 Org: User:

Start: 07/12/23 End: 06/30/27 Due: 06/30/28

Frontier Registry II Bifurcation Stent System Registry

Phase: N/A Priority: Normal

NCT ID: NCT00286195 Org: User:

Start: 12/31/04 End: 12/31/06 Due: 12/31/07

XIENCE V/PROMUS Everolimus-Eluting Stent System Post-marketing Surveillance Protocol for Japan

Phase: N/A Priority: Normal

NCT ID: NCT01086228 Org: User:

Start: 03/31/10 End: 08/31/16 Due: 08/31/17

Occipital Nerve (C2) Stimulation in the Treatment of Fibromyalgia

Phase: N/A Priority: Normal

NCT ID: NCT01298609 Org: User:

Start: 06/30/10 End: 01/31/13 Due: 01/31/14

MOMENTUM 3 Pivotal Cohort Extended Follow-up PAS

Phase: N/A Priority: Normal

NCT ID: NCT03982979 Org: User:

Start: 06/20/19 End: 09/08/21 Due: 09/08/22

Thoratec HeartMate II Left Ventricular Assist System (LVAS) for Bridge to Cardiac Transplantation

Phase: N/A Priority: Normal

NCT ID: NCT00121472 Org: User:

Start: 03/31/05 End: 05/31/10 Due: 05/31/11

BOOST - Benefit of Frequent Optimization After Cardiac Resynchronization Therapy Device Replacement

Phase: N/A Priority: Normal

NCT ID: NCT00929474 Org: User:

Start: 06/30/09 End: 09/30/10 Due: 09/30/11

Aveir AR Coverage With Evidence Development (CED) Study

Phase: N/A Priority: Normal

NCT ID: NCT06100770 Org: User:

Start: 01/18/24 End: 01/31/31 Due: 01/31/32

Atrial Flutter Ablation With Contact Therapy Cool Path Ablation System Along With EnSite Velocity Contact System

Phase: N/A Priority: Normal

NCT ID: NCT01401361 Org: User:

Start: 10/31/11 End: 09/30/12 Due: 09/30/13

ABLATOR Brazil - Ablation Observational Study (Registry)

Phase: N/A Priority: Normal

NCT ID: NCT03041233 Org: User:

Start: 04/13/17 End: 04/27/20 Due: 04/27/21

BurstDR™ micrOdosing stimuLation in De-novo Patients

Phase: N/A Priority: Normal

NCT ID: NCT03350256 Org: User:

Start: 10/30/17 End: 07/02/19 Due: 07/02/20

XIENCE V® Everolimus Eluting Coronary Stent System USA Post-Approval Study (XIENCE V® USA-Phase 1)

Phase: N/A Priority: Normal

NCT ID: NCT00676520 Org: User:

Start: 07/31/08 End: 03/31/11 Due: 03/31/12

Abbott Vascular Medical Device Registry

Phase: N/A Priority: Normal

NCT ID: NCT04573660 Org: User:

Start: 10/25/20 End: 11/30/31 Due: 11/30/32

PAR I - Patient-to-Annulus Relation I

Phase: N/A Priority: Normal

NCT ID: NCT02981004 Org: User:

Start: 10/31/12 End: 12/18/17 Due: 12/18/18

Assert-IQ Implantable Cardiac Monitor (ICM) Post Market Study

Phase: N/A Priority: Normal

NCT ID: NCT06172699 Org: User:

Start: 01/01/24 End: 12/24/25 Due: 12/24/26

Topera E-FIRM Registry

Phase: N/A Priority: Normal

NCT ID: NCT02386345 Org: User:

Start: 03/31/15 End: 07/31/18 Due: 07/31/19

FIRM Ablation Versus Pulmonary Vein Isolation for the Treatment of Paroxysmal Atrial Fibrillation (PAF)

Phase: N/A Priority: Normal

NCT ID: NCT02703454 Org: User:

Start: 02/29/16 End: 02/28/18 Due: 02/28/19

TARGET Post-Approval Study

Phase: N/A Priority: Normal

NCT ID: NCT02800863 Org: User:

Start: 08/23/16 End: 09/23/21 Due: 09/23/22

Safety and Effectiveness Evaluation of Peripheral Orbital Atherectomy

Phase: N/A Priority: Normal

NCT ID: NCT05529472 Org: User:

Start: 01/10/23 End: 10/10/24 Due: 10/10/25

Closure of Muscular Ventricular Septal Defects (VSDs) With the AMPLATZER Muscular VSD (MuVSD) Occluder - Post Approval Study

Phase: N/A Priority: Normal

NCT ID: NCT00647387 Org: User:

Start: 03/31/08 End: 02/23/24 Due: 02/23/25

SPIRIT V: Post-marketing Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System in Europe

Phase: N/A Priority: Normal

NCT ID: NCT00402272 Org: User:

Start: 11/30/06 End: 06/30/10 Due: 06/30/11

Title	NCT ID	Organization	User	Status	Start Date	End Date	Reporting Due Date	Last Checked	User Role	Org Created
Observational Study of Prosthetic Tissue Aortic and Mitral Heart Valve	NCT00329667	Abbott Medical Devices	user2@example.com	None	2003-01-31	2008-09-30	2009-09-30	-	-	2025-07-14
TactiCath® Prospective Effectiveness Pilot Study	NCT02131337	Abbott Medical Devices	user2@example.com	None	2010-12-31	2011-10-31	2012-10-31	-	-	2025-07-14
MitraClip EXPAND G4 Study	NCT04177394	Abbott Medical Devices	user2@example.com	None	2020-01-17	2028-03-31	2029-03-31	-	-	2025-07-14
To Pace or Not to Pace in Sinus Node Disease	NCT02485093	Abbott Medical Devices	user2@example.com	None	2009-06-30	2014-10-31	2015-10-31	-	-	2025-07-14
Amulet™ ADVANCE LAA	NCT05997446	Abbott Medical Devices	user2@example.com	None	2023-07-12	2027-06-30	2028-06-30	-	-	2025-07-14
Frontier Registry II Bifurcation Stent System Registry	NCT00286195	Abbott Medical Devices	user2@example.com	None	2004-12-31	2006-12-31	2007-12-31	-	-	2025-07-14
XIENCE V/PROMUS Everolimus-Eluting Stent System Post-marketing Surveillance Protocol for Japan	NCT01086228	Abbott Medical Devices	user2@example.com	None	2010-03-31	2016-08-31	2017-08-31	-	-	2025-07-14
Occipital Nerve (C2) Stimulation in the Treatment of Fibromyalgia	NCT01298609	Abbott Medical Devices	user2@example.com	None	2010-06-30	2013-01-31	2014-01-31	-	-	2025-07-14
MOMENTUM 3 Pivotal Cohort Extended Follow-up PAS	NCT03982979	Abbott Medical Devices	user2@example.com	None	2019-06-20	2021-09-08	2022-09-08	-	-	2025-07-14
Thoratec HeartMate II Left Ventricular Assist System (LVAS) for Bridge to Cardiac Transplantation	NCT00121472	Abbott Medical Devices	user2@example.com	None	2005-03-31	2010-05-31	2011-05-31	-	-	2025-07-14
BOOST - Benefit of Frequent Optimization After Cardiac Resynchronization Therapy Device Replacement	NCT00929474	Abbott Medical Devices	user2@example.com	None	2009-06-30	2010-09-30	2011-09-30	-	-	2025-07-14
Aveir AR Coverage With Evidence Development (CED) Study	NCT06100770	Abbott Medical Devices	user2@example.com	None	2024-01-18	2031-01-31	2032-01-31	-	-	2025-07-14
Atrial Flutter Ablation With Contact Therapy Cool Path Ablation System Along With EnSite Velocity Contact System	NCT01401361	Abbott Medical Devices	user2@example.com	None	2011-10-31	2012-09-30	2013-09-30	-	-	2025-07-14
ABLATOR Brazil - Ablation Observational Study (Registry)	NCT03041233	Abbott Medical Devices	user2@example.com	None	2017-04-13	2020-04-27	2021-04-27	-	-	2025-07-14
BurstDR™ micrOdosing stimuLation in De-novo Patients	NCT03350256	Abbott Medical Devices	user2@example.com	None	2017-10-30	2019-07-02	2020-07-02	-	-	2025-07-14
XIENCE V® Everolimus Eluting Coronary Stent System USA Post-Approval Study (XIENCE V® USA-Phase 1)	NCT00676520	Abbott Medical Devices	user2@example.com	None	2008-07-31	2011-03-31	2012-03-31	-	-	2025-07-14
Abbott Vascular Medical Device Registry	NCT04573660	Abbott Medical Devices	user2@example.com	None	2020-10-25	2031-11-30	2032-11-30	-	-	2025-07-14
PAR I - Patient-to-Annulus Relation I	NCT02981004	Abbott Medical Devices	user2@example.com	None	2012-10-31	2017-12-18	2018-12-18	-	-	2025-07-14
Assert-IQ Implantable Cardiac Monitor (ICM) Post Market Study	NCT06172699	Abbott Medical Devices	user2@example.com	None	2024-01-01	2025-12-24	2026-12-24	-	-	2025-07-14
Topera E-FIRM Registry	NCT02386345	Abbott Medical Devices	user2@example.com	None	2015-03-31	2018-07-31	2019-07-31	-	-	2025-07-14
FIRM Ablation Versus Pulmonary Vein Isolation for the Treatment of Paroxysmal Atrial Fibrillation (PAF)	NCT02703454	Abbott Medical Devices	user2@example.com	None	2016-02-29	2018-02-28	2019-02-28	-	-	2025-07-14
TARGET Post-Approval Study	NCT02800863	Abbott Medical Devices	user2@example.com	None	2016-08-23	2021-09-23	2022-09-23	-	-	2025-07-14
Safety and Effectiveness Evaluation of Peripheral Orbital Atherectomy	NCT05529472	Abbott Medical Devices	user2@example.com	None	2023-01-10	2024-10-10	2025-10-10	-	-	2025-07-14
Closure of Muscular Ventricular Septal Defects (VSDs) With the AMPLATZER Muscular VSD (MuVSD) Occluder - Post Approval Study	NCT00647387	Abbott Medical Devices	user2@example.com	None	2008-03-31	2024-02-23	2025-02-23	-	-	2025-07-14
SPIRIT V: Post-marketing Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System in Europe	NCT00402272	Abbott Medical Devices	user2@example.com	None	2006-11-30	2010-06-30	2011-06-30	-	-	2025-07-14

Compliance Rate

My Organizations' Clinical Trials

Appearance